- Info
FT.com - Drugs and Healthcare
FT.com - Drugs and Healthcare
| Dec 05, 2008 |
Big boost for science training
A thousand more scientists and engineers will receive postgraduate training to PhD level, after a £250m investment over five years announced today by the...
|
| Dec 05, 2008 |
Novartis hopes success with malaria will aid second drug
Novartis, the Swiss pharmaceutical group, plans to use likely US approval of its malaria medicine Coartem to ease the regulatory pain and boost the profits of another...
|
| Dec 04, 2008 |
Biotech calls for support from government
A group of leading biotechnology industry figures has warned of a collapse unless the UK government comes up with £500m to match private investors' funds to trigger consolidation.
|
| Dec 04, 2008 |
Drugs case on fixing of prices collapses
One of the longest-running and most expensive criminal prosecutions collapsed yesterday after the Court of Appeal refused to reinstate charges against a group of...
|
| Dec 04, 2008 |
Drugs trial payout victory
A retired Cambridge professor has won the right to compensation from Merck, the US pharmaceutical group, for severe side effects developed after he took Vioxx, its...
|
| Dec 02, 2008 |
Claimar bemoans organic setback
The nursing care provider suspended its final dividend in spite of having two acquisitions that helped the company to more than double annual turnover
|
| Dec 01, 2008 |
Strong medicine
If EU policymakers want to stimulate innovative new drugs, they must promote public investment in medical research, improving the climate for clinical trials
|
| Dec 01, 2008 |
Johnson & Johnson in $1bn Mentor buy
Johnson & Johnson has agreed to buy Mentor Corporation, a top maker of breast implants, for $1.07bn in cash in order to offer doctors a broader range of aesthetic and reconstructive medical products
|
| Dec 01, 2008 |
Scientists plan 'Big Brother' flu experiment
UK researchers plan to recruit 200 volunteers to be infected with the virus while living together under constant camera observation and medical supervision to deepen study on tackling a pandemic
|
| Nov 29, 2008 |
Brussels warns pharma groups
The European Commission yesterday threatened anti-trust cases against pharmaceutical companies that have used legal tactics to delay the launch of generic medicines at...
|
| Nov 29, 2008 |
Drugmakers give Footsie shot in arm
Drugmakers yesterday helped the FTSE 100 achieve its biggest weekly rise. GlaxoSmithKline and AstraZeneca moved higher after a European Union antitrust...
|
| Nov 28, 2008 |
EU probe finds companies block cheap drugs
Drug companies have blocked or delayed the market entry of cheaper generic medicines to Europe, adding billions to the cost of medicines to patients, a high-profile report from Brussels has found
|
| Nov 27, 2008 |
Assura set for cuts after review
Increased rental income and higher sales at its wholly owned pharmacies have boosted turnover at Assura, the healthcare services company that provides clinical...
|
| Nov 26, 2008 |
Pharma groups are raided ahead of report
Brussels has raided drug companies it suspects of breaching competition rules days before regulators are to unveil interim findings from a year-long probe into the sector
|
| Nov 26, 2008 |
Your true identity revealed in the palm of one hand
Most of us are familiar with the need to prove our identity, whether to access a computer network, liaise with our bank or get into a place of work. But the most...
|
| Nov 26, 2008 |
Lupuzor deal lifts Immupharma
Shares in Immupharma, the biotechnology group, rose almost 30 per cent after it signed an option agreement with Cephalon, the US pharmaceutical company, to outlicense...
|
| Nov 25, 2008 |
UK scientists warn on funding for stem cell
Universities, industry and charities say Britain will lose its global lead in regenerative medicine research unless the government does more to help translate the science into clinical trials
|
| Nov 25, 2008 |
Drug trial hope for Vectura
The maker of inhaled medicines reports an 8.5% increase in revenue and is looking forward to two of its pulmonary disease drugs entering late stage clinical trials next year
|
| Nov 25, 2008 |
Roche scraps skyscraper HQ
Roche decided yesterday against the curvaceous skyscraper that would have served as its eye-catching new Basel headquarters, in a move immediately seen as a...
|
| Nov 25, 2008 |
E2V bullish on full year
E2V Technologies, the maker of electronic components used in defence systems and medical equipment, increased its interim dividend 10 per cent to 2.7p after lifting...
|
Forgotten your Password?
Register?
